SCHEMBL6207862

SCHEMBL6207862

N[C@H](CO)CCc1nc(-c2ccccc2)no1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.60
RAB9A P51151 6/20 0.57
L3MBTL1 Q9Y468 5/20 0.57
NPC1 O15118 5/20 0.57
CYP1A2 P05177 2/20 0.57
CYP2C19 P33261 2/20 0.57
ALDH1A1 P00352 4/20 0.55
HTR1A P08908 1/20 0.51
HRH3 Q9Y5N1 1/20 0.51
GAA P10253 1/20 0.49
HDAC1 Q13547 2/20 0.48
HDAC2 Q92769 2/20 0.48
HDAC8 Q9BY41 2/20 0.48
MAPK1 P28482 3/20 0.48
TDP1 Q9NUW8 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
TSHR P16473 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
CYP2D6 P10635 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27146530 0.82 ALDH1A1 (0.60) NOTUMRAB9AL3MBTL1NPC1CYP1A2
SCHEMBL27032985 0.82 ALDH1A1 (0.60) NOTUMRAB9AL3MBTL1NPC1CYP1A2
Hydrochloric Acid SCHEMBL29096793 0.81 ALDH1A1 (0.59) NOTUMRAB9AL3MBTL1NPC1CYP1A2
SCHEMBL8564550 0.77 SIRT2 (0.72) NOTUMRAB9AL3MBTL1NPC1CYP1A2
SCHEMBL14736563 0.77 RAB9A (0.70) NOTUMRAB9AL3MBTL1NPC1CYP1A2
SCHEMBL17595755 0.76 NOTUM (1.00) NOTUMRAB9AL3MBTL1NPC1CYP1A2
SCHEMBL27745691 0.76 ALDH1A1 (0.60) NOTUMRAB9AL3MBTL1NPC1CYP1A2
Hydrochloric Acid SCHEMBL29828714 0.76 HPGD (0.55) NOTUMRAB9AL3MBTL1NPC1CYP1A2
SCHEMBL6206857 0.74 NOTUM (0.60) NOTUMRAB9AL3MBTL1NPC1ALDH1A1
SCHEMBL7977108 0.74 ALDH1A1 (0.69) NOTUMRAB9AL3MBTL1NPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515726-A1 MORPHOLINE AND TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2005-03-23 EP disclosed
WO-2004002491-A1 MORPHOLINE AND TETRAHYDROPYRAN DRIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2004-01-08 WO disclosed